Search

Your search keyword '"Orlando, A."' showing total 556 results

Search Constraints

Start Over You searched for: Author "Orlando, A." Remove constraint Author: "Orlando, A." Journal digestive and liver disease Remove constraint Journal: digestive and liver disease
556 results on '"Orlando, A."'

Search Results

1. Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)

2. Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey

4. Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study

5. Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology

7. A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

9. Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology

10. Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy

13. OC.07.5: BOWEL URGENCY IN PATIENTS WITH ULCERATIVE COLITIS: PREVALENCE AND ASSOCIATION WITH CLINICAL, ENDOSCOPIC DATA AND DISABILITY

15. OC.18.7: HIDDEN SHORT BOWEL SYNDROME IN CROHN'S DISEASE: A NATIONAL SURVEY

16. OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY (AVENUE) PATIENTS WITH CROHN'S DISEASE (CD): AN IG-IBD STUDY

19. A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

20. The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

26. Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)

27. Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey

31. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

33. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn’s Disease

34. Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP)

41. Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study

44. Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease

45. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

47. Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology

48. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

49. T.06.2 USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE

50. OC.14.6 ATTITUDES TOWARDS VACCINATIONS IN AN ITALIAN COHORT OF IBD PATIENTS

Catalog

Books, media, physical & digital resources